NINGBO INNO PHARMCHEM CO.,LTD. Logo
Home Contact Us
  1. Home
  2. News Tag: Oncology Portfolio

News Articles Tagged: Oncology Portfolio

Sorafenib Tosylate: A Key Inhibitor in NINGBO INNO PHARMCHEM's Oncology Portfolio

NINGBO INNO PHARMCHEM details the comprehensive profile of Sorafenib Tosylate, focusing on its multi-kinase inhibition, applications in kidney, liver, and thyroid cancers, and its significance in pharmaceutical supply.

Start Your Journey to Higher Quality

Reach out to our technical specialists today for customized solutions, samples, and a detailed quote. We are excited to build a brilliant future together.

Send an Inquiry by Email

NINGBO INNO PHARMCHEM CO.,LTD.

Add: 163 Ruiqing Road,Ningbo Zhejiang 315000 China | Tel:+86 574 87319282 / 87314919

© 2025 All Rights Reserved.